Barlesi, F., Vansteenkiste, J., Spigel, D., Ishii, H., Garassino, M., de Marinis, F., Özgüroğlu, M., Szczesna, A., Polychronis, A., Uslu, R., Krzakowski, M., Lee, J., Calabrò, L., Arén Frontera, O., Ellers-Lenz, B., Bajars, M., Ruisi, M., & Park, K. (2018). avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study. Lancet oncology, 19(11), 1468–1479. http://access.bl.uk/ark:/81055/vdc_100071726609.0x000012